🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We propose to use an inhaled allergen challenge model to explore the indivi...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05
Trial ID
NCT01128595
Treatments Being Tested
This will be a single-centre, randomised, double blind, placebo controlled,...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-12-22
Trial ID
NCT00866515
Treatments Being Tested
This is a study of GW642444M, a long-acting beta 2 specific agonist. This s...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08
Trial ID
NCT00381667
We propose to use an inhaled allergen challenge model to explore the indivi...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01
Trial ID
NCT01128569
Treatments Being Tested
This is a randomized, double blind, placebo controlled, parallel-group, 7 d...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-20
Trial ID
NCT00964249
This study will involve the use of a new compound, GW642444 that is being d...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00519376
A randomized two-way crossover study to determine whether concomitant admin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01165125
Treatments Being Tested
This study will involve the use of a new medicine called GW642444 being dev...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-27
Trial ID
NCT00702910
Treatments Being Tested
A randomised, placebo controlled thorough QTc study to evaluate the effect ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-23
Trial ID
NCT01209026
This study will involve the use of a new compound, GW642444 that is being d...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-02
Trial ID
NCT00463697
Treatments Being Tested